Study of MAR001 for people with high triglycerides and remnant cholesterol
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called MAR001 in people with high triglycerides and remnant cholesterol, which are types of fats in the blood. It aims to see if the medicine can improve these levels while you stick to your usual diet and medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to follow the study plan and give your consent.
- Your fasting triglyceride levels need to be checked twice, at least a week apart, during screening.
- Your hemoglobin A1c (average blood sugar over 3 months) should be between 5.7% and 8.5%.
- You must have been eating a stable diet for at least 3 months before screening and keep it that way during the study.
- Your medications (if any) should be stable before and during the study, with no planned changes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This trial tests a new injectable drug, JMT202, for people with high triglycerides (a type of fat in the blood). The goal is to see if it safely lowers triglycerides and may reduce heart risk.
This trial tests a new injectable drug called DR10624 for people with very high triglyceride levels. It aims to lower triglycerides and reduce the risk of pancreatitis (inflammation of the pancreas).
This trial tests an investigational drug called TLC-2716 for people with very high triglycerides and a type of fatty liver disease (NAFLD or NASH). The goal is to see if it is safe and can help lower fat levels in the blood and liver.
This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.
Hear when a new Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.